038460 — BioSmart Co Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologySpeculativeSmall CapNeutral

Annual cashflow statement for BioSmart Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-11,505	634	-1,182	16,179	1,055
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	11,545	10,056	11,345	-1,422	19,086
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-12,841	-13,981	-14,132	-22,081	-24,547
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-7,487	2,328	5,587	1,166	3,798
Capital Expenditures	-9,256	-5,754	-5,867	-4,917	-8,661
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	12,054	-26,043	154	-3,917	-164
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	2,798	-31,797	-5,714	-8,834	-8,825
Financing Cash Flow Items	-1,281	0	—	-150	5,946
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,183	24,596	6,193	8,910	-5,025
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-5,874	-4,843	6,027	1,239	-10,040